Sangamo Biosciences, Inc. (NASDAQ:SGMO), the leader in therapeutic genome editing, announced that the U.
Sangamo Biosciences, Inc. (NASDAQ:SGMO), the leader in therapeutic genome editing, announced the presentation of Phase 2 data from two of the Company’s ongoing …
Analysts weighed in today on the coffee giant Keurig Green Mountain Inc (NASDAQ:GMCR) and biotechnology company Sangamo Biosciences, Inc. (NASDAQ:SGMO), as news of buyout deal that …
Liana Moussatos of Wedbush rates stocks in the biotechnology sector and is one of the top 50 analysts rated on TipRanks. Today, Moussatos reiterated ratings for …
In light of developments from the FDA, analysts remain bullish on both Relypsa Inc (NASDAQ:RLYP) and Sangamo Biosciences, Inc. (NASDAQ:SGMO).
Sangamo BioSciences, Inc. (NASDAQ:SGMO), the leader in therapeutic genome editing, announced that the U.
Sangamo Biosciences, Inc. (NASDAQ:SGMO), a leader in therapeutic genome editing, announced today the publication in Nature Biotechnology of data demonstrating efficient zinc finger …
Sangamo Biosciences, Inc. (NASDAQ:SGMO), a leader in therapeutic genome editing, announced today that non-human primate data from its proprietary In Vivo Protein Replacement …
Sangamo Biosciences, Inc. (NASDAQ:SGMO) reported its third quarter 2015 financial results and accomplishments.
Sangamo Biosciences, Inc. (NASDAQ:SGMO) presented data demonstrating sustained functional control of viral load in the absence of antiretroviral drugs (ART) in two of …
